The vast majority of proteins are posttranslationally altered, with the addition of covalently linked sugars (glycosylation) being one of the most abundant modifications. However, despite the hydrolysis of protein peptide bonds by peptidases being a process essential to all life on Earth, the fundamental details of how peptidases accommodate posttranslational modifications, including glycosylation, has not been addressed. Through biochemical analyses and X-ray crystallographic structures we show that to hydrolyze their substrates, three structurally related metallopeptidases require the specific recognition of O-linked glycan modifications via carbohydrate-specific subsites immediately adjacent to their peptidase catalytic machinery. The three peptidases showed selectivity for different glycans, revealing protein-specific adaptations to particular glycan modifications, yet always cleaved the peptide bond immediately preceding the glycosylated residue. This insight builds upon the paradigm of how peptidases recognize substrates and provides a molecular understanding of glycoprotein degradation.
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O-glycopeptidase | metallopeptidase | glycoprotein | O-glycosylation P eptidases catalyze the hydrolysis of the peptide bonds in proteins and, by this activity, play fundamental roles in an enormous variety of critical biological processes across all of the taxonomic kingdoms. These enzymes can be classified by their catalytic mechanisms into seven groupings: serine (S), cysteine (C), threonine (T), aspartic (A), glutamic (G), asparagine (N), metallo (M), or asparagine lyase (N) catalytic types (1) . Each grouping of catalytic types has been broken into a robust classification of >240 families, which are based on amino acid sequence identity, whereas the categorization of >50 clans reflects the structural similarities between the families (https://merops.sanger.ac.uk) (1) . This classification contains >0.9 million putative peptidase sequences but only <0.5% of these have been experimentally verified, suggesting that we are far from a complete understanding of how this vast sequence space translates into variable substrate specificities and biological outcomes.
With billions of sequences for known or putative proteins in the protein databases, the variety of possible peptidase substrates is vast. For example, the human genome encodes for ∼600 peptidases, yet over 17,000 genes are known to be transcribed and translated into unique protein products that are possible substrates for the encoded peptidases (2, 3) . This highlights one of the major challenges in characterizing peptidase specificity and identifying specific substrates (4) . Furthermore, the diversity in substrates is substantially increased by posttranslational modifications. Indeed, upwards of 50% of proteins are thought to be posttranslationally modified with glycosylation being one of the most abundant alterations (5) . Typically, protein glycosylation constitutes glycans attached to asparagine side chains (N linked) or serine/threonine side chains (O linked). The structures of glycans attached to a given site can be variable, giving glycoforms of a protein. For example, there are eight distinct core O-glycan structures, all covalently α-linked via an N-acetylgalactosamine (GalNAc) moiety to the hydroxyl group of serine or threonine side chains (6) . Furthermore, the degree of glycosylation is protein dependent, but the average mucin protein is ∼50% O-linked glycans by mass, and the glycans tend to be very heterogeneous by virtue of differing extensions and branching of the core structures (6) . The abundance and frequency of posttranslational modification to proteins, particularly large additions like glycans, suggests a need for peptidases to accommodate more than just the peptide component of the substrate. Indeed, there is evidence that some peptidases are selective for heavily O-glycosylated proteins; however, the molecular basis of how these enzymes recognize substrates is entirely unknown.
Peptidases with known selectivity for heavily O-glycosylated proteins include O-sialylglycoprotease from Mannheimia haemolytica (formerly classified into the deleted MEROPS family M22) (7), StcE from Escherichia coli (family M66) (8) , viral enhancins (family M60) (9) , and some serine protease autotransporters produced by enteric pathogens (SPATEs proteins; family S6) (10) . Similarly, BT4244 from Bacteroides thetaiotaomicron (11), IMPa from Pseudomonas aeruginosa (12) , and SslE from E. coli (13) also display selectivity for glycosylated proteins. These three latter extracellular peptidases are members of the recently defined Pfam family PF13402 (also annotated as "peptidase M60, enhancin, and enhancin-like" or "M60-like") (11). This family, which is in part defined by the possession of a conserved HEXXH(8,24)E gluzincin metallopeptidase motif (14) , is distributed widely among prokaryotes and eukaryotes and was proposed by Nakjang et al. to
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Protein glycosylation is one of the most abundant and important posttranslational modifications where the protein-linked glycans can impart specific physiochemical properties to the glycoprotein and/or the glycans themselves can mediate particular biological functions. The degradation of glycosylated proteins in normal or pathogenic processes, therefore, is an important biological process. This study reveals the molecular basis of how peptidases can use the O-glycans present on glycoproteins as a critical determinant of peptidase activity and, in doing so, provides unique insight into how peptidases may directly use posttranslational modifications present on their substrates to influence recognition and peptide bond cleavage.
comprise glycoprotein-specific peptidases (11) . Although the Pfam classification of these three peptidases indicates an evolutionary relationship between them, BT4244, IMPa, and SslE are classified into the separate MEROPS families M60, M88, and M98, respectively.
Through their ability to cleave O-glycoproteins, many of these peptidases have important roles in cell biology (10, 12, 15) , have been implicated in bacterial pathogenesis (16) (17) (18) , or have found use as reagents (7) . Despite the functional significance of O-glycoprotein degrading peptidases, however, their mode of action on O-glycoproteins is unidentified. To obtain insight into how peptidases select for glycosylated substrates, we focused our studies on the model examples BT4244, IMPa, and ZmpB (locus tag CPF_1489) from Clostridium perfringens (strain ATCC 13124), the latter of which is a member of the Pfam M60-like family but is not classified into a MEROPS family. Biochemical analysis of their peptidase activity revealed the absolute requirement of a glycosylated substrate, whereas the first structural studies of these enzymes by X-ray crystallography in complex with O-glycosylated amino acids and an O-glycopeptide product of catalysis uncovered specific carbohydrate-binding subsites immediately adjacent to the catalytic machinery, thus providing unprecedented insight into the molecular details of how the posttranslational modification of a peptidase substrate can determine enzyme specificity.
Results
In Vitro Peptidase Activity. Our target proteins possessed complex multimodularity (SI Appendix , Fig. S1 ); thus, to advance their study, gene fragments encoding the M60-like domains of BT4244 and ZmpB (referred to as BT4244_m and ZmpB_m, respectively) were expressed in E. coli. IMPa was similarly produced but as a full-length protein. Treatment of highly O-glycosylated bovine submaxillary mucin (BSM) with BT4244_m resulted in a clear change in the electrophoretic mobility of BSM, whereas IMPa and ZmpB_m gave nearly complete clearing of the BSM (Fig. 1A) . We also used a microtiter plate-based mucinase assay using immobilized biotinylated BSM as a substrate and all three peptidases also displayed activity in this assay (SI Appendix, Fig. S2 ). These results were consistent with the reported activity of BT4244 and IMPa on glycoprotein substrates (11, 12) , while revealing comparable properties for ZmpB_m. In all cases, EDTA treatment of the enzymes abolished activity, supporting their assignment as metallopeptidases, as did mutation of the putative catalytic glutamate in the gluzincin motif ( Fig. 1A and SI Appendix, Fig. S2 ). When bovine fetuin, also a glycosylated protein, was used as a substrate, only BT4244_m displayed no obvious effect on the substrate, suggesting some differential selectivity among the three enzymes (Fig. 1A) . When chemically desialylated bovine fetuin (asialofetuin) was used as a substrate, only IMPa retained activity on the substrate. Furthermore, the peptidases displayed different abilities to cleave a variety of additional glycoproteins, which was also abolished by the addition of EDTA into the reactions (SI Appendix, Fig. S3 ). This observation of differential activity of glycoproteins points to further selectivity among the enzymes for different glycoprotein substrates. Most notably, the lack of ZmpB_m activity on asialofetuin versus fetuin suggested a dependence of its activity on the presence of sialic acid, which led us to postulate that glycans are a critical feature in the recognition of substrate by this enzyme and possibly BT4244_m and IMPa.
Peptidase Activity on Defined Synthetic O-Glycopeptides. Given the ability of these enzymes to degrade highly O-glycosylated proteins, we examined their potential O-glycan dependence by assessing activity on defined chemoenzymatically prepared O-glycopeptide substrates. A 15mer synthetic peptide (F15: GAEAEAPSAVPDAAG) containing the S271 O-glycosylation site in fetuin was sequentially glycosylated using specific glycosyltransferases to install an α-linked GalNAc on the serine (also called Tn-antigen; glycopeptide referred to as F15-TnAg), then extend the monosaccharide to the core-1 Galβ1-3GalNAc (T-antigen; F15-TAg), and finally to modify the disaccharide to the α-2,3-Neu5Ac monosialylated core-1 O-glycopeptide (F15-S2,3TAg). As determined by TLC, none of the three enzymes were able to cleave the unglycosylated F15 peptide (Fig. 1B) . ZmpB_m had no apparent affect on any glycosylated peptide. In contrast, treatment of the three glycosylated peptides with IMPa resulted in complete conversion of the peptides into two new products, whereas BT4244_m treatment resulted in partial conversion of F15-TnAg into the same products observed from IMPa activity on this O-glycopeptide (Fig. 1B) . Given the inactivity of ZmpB_m on F15-S2,3TAg, yet its apparent dependence on sialic acid for activity on fetuin, we also generated BDPF15-S2,6TAg, which is the F15 peptide bearing Galβ1-3(Neu5Acα2-6)GalNAc glycan and labeled with BODIPY at the N terminus. Due to limiting amounts of this peptide, we were unable to use ninhydrin to visualize all of the peptide fragments generated by the peptidases; however, the BODIPY label was visible to the eye, allowing facile visualization of peptide fragments possessing this label. Both ZmpB_m and IMPa were able to convert BDPF15-S2,6TAg peptide to a new product, indicating activity on this peptide, whereas the peptide treated with BT4244_m remained unchanged (Fig. 1C) . Finally, we assessed the activity of these enzymes on the Tn-modifed MUC-1 peptide [MUC-1(Tn): PAPGS(GalNAcα1-)TAPPAHGV(GalNAcα1-)TSAPDTRPAPG]. None of the enzymes had any activity on the nonglycosylated peptide (Fig. 1D) . MUC-1(Tn) displayed no mobility on the TLC plates under the solvent conditions used, and this was unchanged after treatment of the peptide with ZmpB_m (Fig. 1D) . Treatment of MUC-1(Tn) with IMPa, however, generated a single new and resolvable product, indicating activity on this peptide. The activity of BT4244_m resulted in two new products that had mobilities distinct from the product produced by IMPa (Fig. 1D) .
To interrogate the point of cleavage on these structurally defined and homogeneous peptides, we used liquid chromatography (LC)-MS to examine the specific cleavage of F15-TnAg, BDPF15-S2,6TAg, and MUC-1(Tn) ( Fig. 2A) . Consistent with the TLC results, ZmpB_m showed no activity on F15-TnAg or MUC-1 (Tn), whereas BT4244_m had no activity on BDPF15-S2,6TAg (Fig. 2B ). In contrast, treatment of F15-TnAg with IMPa or BT4244_m revealed the same set of two product peaks for both enzymes. Their masses were within 0.01 Da of the masses predicted for the peptide fragments GAEAEAP 7 and GalNAcα1-S 8 AVPDAAG (Fig. 2C) , clearly revealing the identity of these peptides and the cleavage point at the peptide bond immediately preceding the glycosylated residue S8. Using LC-tandem MS (LC-MS/MS) we confirmed the identity of these cleavage products (SI Appendix, Fig. S4 ). Similarly, treatment of BDPF15-S2,6TAg with IMPa and ZmpB_m resulted in the same set of two product peaks for each enzyme, which again gave accurate masses within 0.02 Da of those predicted for cleavage of the peptide bond immediately preceding the glycosylated amino acid (Fig. 2C) . Finally, the hydrolysis of MUC-1(Tn) by BT4244_m resulted in three product peaks, the masses of which again indicate cleavage of the peptide bonds immediately preceding the glycosylated threonine residues (before residues T6 and T19). In contrast, the hydrolysis of MUC-1(Tn) by IMPa yielded fragments indicating cleavage of the peptide bond preceding the first glycosylated threonine residue (before residue T6) but no cleavage at the second glycosylation site. The single and double cleavage of MUC-1(Tn) by IMPa and BT4244_m, respectively, are generally consistent with the release of the different products visualized by TLC.
These results therefore indicate that the ability of the three peptidases to hydrolyze the O-glycopeptides is carbohydrate dependent. Furthermore, the peptidases showed differential requirements for glycosylation. BT4244_m consistently cleaved only the O-GalNAcylated peptides, but did not tolerate extended sugars. In contrast, IMPa required at least a GalNAc but tolerated the various extended glycans. ZmpB_m appears to be the most specific of the three peptidases by having an absolute requirement for the α-2,6-Neu5Ac present on the peptide-linked GalNAc, likely explaining the sialic acid dependence of this enzyme's activity on fetuin, which commonly bears this sialic acid modification on its O-glycans (19) .
Mammalian Glycan Array Screening. Using mammalian glycan arrays to explore the potential for selective glycan binding by ZmpB_m, BT4244_m, and IMPa resulted in suggestive but inconclusive results for ZmpB_m and BT4244_m, which was likely due to lowaffinity interactions with the array. However, IMPa screening resulted in identifying 31 glycans that displayed a clear interaction with IMPa when using a minimum threshold of 10% of the maximum signal (SI Appendix, Fig. S5 ). Notably, the hits were all glycans built on core-2 [Galβ1-3(GlcNAcβ1-6)GalNAc-Thr], core-4 [GlcNAcβ1-3(GlcNAcβ1-6)GalNAc-Thr], or core-6 [GlcNAcβ1-6GalNAc-Thr] O-glycan motifs and the glycans were all O-linked to threonine residues (Note: the glycoamino acid O-glycan ligands contained only threonine and were not present as the serine versions). Although IMPa was clearly able to hydrolyze a minimally O-glycosylated substrate with only the Tn-or TAg-glycans, the enzyme appeared to have the highest affinity when this core modification is extended with a β-1,6-linked GlcNAc (GlcNAcβ1-6GalNAcα1-Thr). Furthermore, the strict recognition of glycosylated threonine indicates the necessity of the amino acid component for optimal affinity.
X-Ray Crystallographic Analysis of the Peptidase Structures. To examine the molecular basis of substrate selectivity in these enzymes, we determined the high-resolution crystal structures of BT4244_m, ZmpB_m, and IMPa (SI Appendix, Tables S1-S3 for all X-ray data collection and model statistics). BT4244_m and ZmpB_m had very similar architectures comprising two Ig-like fold (Ig) domains separated by a central all-α catalytic domain ( Fig. 3 A and B) . This central domain houses the gluzincin motif that forms the characteristic metallopeptidase catalytic machinery containing the catalytic glutamate and metal binding site ( Fig. 3 A and B) and is similar to the core fold of the gluzincin representative enzyme, thermolysin (SI Appendix, Fig. S6 ). The core catalytic domain of IMPa has the same general characteristics as BT4244_m and ZmpB_m; however, IMPa lacks the C-terminal Ig domain, whereas the N terminus has an α/β-fold domain linked through an α-helix bundle to the Ig domain that precedes the catalytic domain (Fig. 3C) .
Structures of the Peptidases in Complex with O-Glycan Ligands. Using the knowledge that BT4244_m appeared selective for the Tnantigen and that IMPa had broader specificity, we were able to determine the structures of BT4244_m and IMPa in complex with serinyl Tn-antigen (GalNAcα1-Ser; BT4244_m-TnAg) and serinyl T-antigen (Galβ1-3GalNAcα1-Ser; IMPa-TAg), respectively. Both compounds could be easily modeled into electron density maps, although the terminal galactose in the serinyl T-antigen bound to IMPa displayed some disorder as shown by the partial electron density for this sugar (SI Appendix, Fig. S7 A and B) . These complexes revealed a pattern of specific interactions between the GalNAc residues and active site amino acids that was very similar for the two enzymes (Fig. 4 A and B) . The additional galactose residue on the T-antigen of the IMPa complex was oriented into solvent and made no interactions with the protein (Fig. 4B) . Although a phosphate molecule was fortuitously trapped in the IMPa complex, it was not positioned appropriately to participate in substrate recognition. A key difference in the active site architectures of the two enzymes was the presence and positioning of Y538 and D567 in BT4244_m, whereas these residues are absent in IMPa. Y538 and D567 of BT4244_m close in on the C6-hydroxyl of the GalNAc residue and hydrogen bond with it, thus sterically blocking the ability of the protein to recognize substituents linked to O6 of the GalNAc (Fig.  4 A and C) . In contrast, this region of the active site is open in IMPa and contains a tryptophan sidechain (W685; Fig. 4 B and D) that is ideally positioned to make potential CH-π interactions with a GlcNAc residue β-1,6-linked to the core GalNAc (SI Appendix, Fig.  S7C ). Although the structure of the Tn-antigen BT4244_m complex suggests the protein cannot accommodate a modification on the O6 of the GalNAc residue, it provides little insight into the apparent inability of this protein to recognize the T-antigen; however, its seemingly strict requirement for the Tn-antigen likely explains the qualitatively limited activity of BT4244_m on BSM and fetuin, where the Tn-antigen is comparatively rare or nonexistent, respectively (19, 20) .
The determination of the ZmpB_m structure after crystals of the protein were soaked in a solution of BSM yielded a complex with a product of catalysis (ZmpB_m-BSMfrg). A ligand in the active site with clear electron density was readily identifiable as an O-glycopeptide that was modeled as the trisaccharide GlcNAcβ1-3(Neu5Acα2-6)GalNAcα1 (α2,6-sialylated core-3 O-glycan) linked to the threonine residue of a pentapeptide with the proposed sequence TAPGG (SI Appendix, Fig. S7D ). The positioning of the glycosylated N-terminal threonine in this complex was consistent with both the anticipated hydrolytic mechanism of a metallopeptidase and our observation that all of the enzymes hydrolyzed the peptide bond immediately preceding the glycosylated residue (Fig. 5A) . Apart from hydrogen bonding between the peptidase active site and the ligand threonine residue that bears the glycan, the interface between ZmpB_m and the pentapeptide portion of the ligand suggested little to no specificity for the peptide (Fig. 5A) . Indeed, this also revealed ample space in the active site to accommodate the methyl group of the glycosylated threonine, which also appears to be the case with BT4244_m and IMPa, in particular suggesting that the enzymes do not discriminate between serine or threonine at this position.
The pattern of interactions between ZmpB_m and the ligand were sugar specific, including hydrogen bonds between active site amino acids and all three sugar residues (Fig. 5B) . A similar mode of recognition was observed in the subsequently determined structure of ZmpB_m in complex with the α2,6-sialylated core-1 O-glycan, Galβ1-3(Neu5Acα2-6)GalNAcα1-Ser (ZmpB_m-STAg; and SI Appendix, Fig. S7E ). In this complex, however, the β1,3-linked galactose of the ligand results in only a single hydrogen bond between the galactose and the enzyme active site that is mediated by an ethylene glycol molecule, which likely displaced a water molecule during the cryoprotection procedure and acts as a surrogate for this water. In contrast, in the ZmpB_m-BSMfrg complex the presence of the acetamido group of the β1,3-linked GlcNAc in the bound ligand enables one direct and one water-mediated hydrogen bond between this residue and the enzyme active site. This suggests that ZmpB_m may favor β1,3-linked GlcNAc over β1,3-linked galactose in this position. Both structures revealed the sialic acid to be bound in a pocket with a notably basic surface charge that is complementary to the acidic carboxylate on the sialic acid (Fig. 5D ). In contrast, the analogous pocket in IMPa, which is near W685, possesses a relatively neutral or even slightly acidic surface charge (Fig. 4D) . Additional specificity for the α2,6-linked sialic acid is provided by a series of four direct hydrogen bonds between the glycerol sidechain of the sugar and residues in the enzyme active site. Thus, the structural role of Neu5Acα2-6GalNAc in substrate recognition by ZmpB_m is consistent with the sialic acid dependence of its activity on fetuin, which is abundant with this modification, and its activity on the BDPF15-S2,6TAg, but lack of activity on the other tested O-glycopeptides.
Discussion
The M60-like domains of BT4244, ZmpB, and IMPa display low pairwise amino acid sequence identities that vary between 12% and 19%, consistent with their classification into different MEROPS families or, in the case of ZmpB, lacking a classification. Despite the divergent sequences, yet consistent with their larger classification into the Pfam M60-like family, the M60-like catalytic domains of these proteins all share the thermolysin-like fold, complete with the metal binding site housing the catalytic zinc atom, found in the MEROPS metallopeptidase clan MA. Remarkably, these enzymes rely on the recognition of O-linked glycans present on the protein substrate. The O-glycan modifications are accommodated in specific subsites present in the catalytic site such that the peptide bond targeted for hydrolysis immediately precedes the site of glycosylation. BT4244, ZmpB, and IMPa have a primary GalNAcα1-Ser/Thr binding subsite that is largely conserved among the enzymes (Fig.  6A ) and that we consider consistent with the fact that the majority of O-glycan modifications possess the same core GalNAc residue that is α-linked to a serine or threonine residue. Indeed, the active site of BT4244 appears equipped to recognize only this GalNAc residue. In contrast, the catalytic site of ZmpB possesses this primary GalNAc binding site and at least two additional subsites that accommodate the α2,6-Neu5Ac linked to the core GalNAc, which we postulate is a key recognition determinant in this enzyme, and another subsite that binds the β1,3-linked galactose or GlcNAc found in core-1 and core-3 O-glycans, respectively. IMPa has a catalytic site that also accepts branched O-glycans. The structure of IMPa in complex with the serinyl T-antigen indicated no specific interactions between the β1,3-galactose and the enzyme, suggesting this modification is more likely tolerated than a key determinant of recognition, although it is possible that, like in ZmpB, the acetamido group of the β1,3-linked GlcNAc may afford additional interactions with the enzyme. Contrary to this proposal, however, the microarray binding studies revealed that IMPa accommodates both β1,3-linked galactose and GlcNAc, but suggested no preference between them. A clear pattern from the microarray results was that every glycan that IMPa interacted with possessed a β1,6-GlcNAc linked to the GalNAc residue, implying the importance of this moiety for optimal enzyme affinity. Based on the structure of IMPa, we postulate a second subsite that is defined largely by the apolar face of W685 and that binds β1,6-linked GlcNAc (Fig. 4D and SI Appendix, Fig. S7C ); occupation of this subsite would likely translate into increased affinity for the substrate and more efficient enzyme activity. Overall, therefore, these peptidases share a common scaffold that contains the catalytic machinery and a generally conserved primary GalNAc-specific glycan-binding subsite. However, differential recognition of posttranslational O-glycan modifications is imparted by the presence (or lack) of additional glycan-binding subsites that are not conserved among the enzymes (Fig. 6B ) and serve to bind specific extensions to the core GalNAc residue, thus providing specificity to the enzymes. The paradigm of peptidase-substrate recognition is based on the model of Schechter and Berger (21) , which defines specific recognition of amino acids of the substrate (P and P′ residues) by subsites in the enzyme active site (S and S′ subsites) where the scissile bond of the substrate between P1 and P1′ spans the S1 and S1′ subsites (3). This paradigm, although elegant and simple, does not adequately apply to the glycoprotein-specific peptidases studied here. Like the peptide backbone, O-glycans can be composed of multiple different building blocks but, unlike peptides, the monosaccharide building blocks can be linked in multiple different ways to provide substantial structural and chemical diversity in the resulting glycans, which in turn impart to the protein important physiochemical properties and/or biological functions. Thus, the amino acids to which O-glycans are attached are considered more than just modified amino acids. Here we have shown that the diversity of O-glycans can be mirrored in the glycan-binding subsites of M60-like peptidases, where each subsite recognizes a unique building block of the O-glycan. As the interaction of the glycan subsites with substrate are a critical component of substrate recognition by this class of peptidases, which we refer to as O-glycopeptidases, the glycanspecific subsites bear explicit consideration. Therefore, in the case of O-glycopeptidases, we promote an update to the paradigm of peptidase-substrate recognition to include what we refer to as "G sites" that accommodate the O-glycan (Fig. 7A) . This model incorporates the potential presence of specific peptide recognition elements (S and S′ subsites) with the G subsites that can recognize a simple O-linked sugar modification, as in the case of BT4244 (Fig. 7B) , or more complex glycans, as in the cases of ZmpB (Fig. 7C) and IMPa (Fig. 7D) .
The importance of the substrate's amino acid sequence to the activity of BT4244, ZmpB, and IMPa remains unclear. However, other than the frequent proximity of a proline to the site of A B General model for O-glycopeptidase substrate recognition presenting the common subsite paradigm for peptidases with the substrate residues (P) and the corresponding peptidase subsites (S) numbered outwards from the cleaved bond, which is indicated by a red triangle. The proposed glycan sites are depicted as G, with G1′ as GalNAc, which can be branched via its O6 (G2′) or O3 (G2′′). Specific representations using this model to show the subsites of (B) BT_4244, (C) ZmpB, and (D) IMPa. Question marks represent the unknown presence of S subsites in the enzyme and P residues in the substrate.
glycosylation we note that there is a lack of an unambiguous consensus motif for O-glycosylation sites (22) . Whereas this lack does not preclude preference of a specific amino acid sequence in the substrate of these peptidases, their reliance on the presence of glycosylation combined with recognition of a specific amino acid sequence would likely result in ultrarare cleavage sites, which given the strong depolymerizing activity of these enzymes on BSM seems unlikely. Some support for this argument is given by the limited interaction observed between ZmpB_m and the peptide portion of a bound O-glycopeptide, which indicated only an S1′ subsite that accommodated the glycosylated residue and no clearly definable additional S′ subsites (Fig. 5A) . The presence of any S subsites is unknown, as these were not occupied in any of the crystal structures we obtained. Furthermore, as an example, the enzyme BT4244_m cleaved two different peptides at a total of three different glycosylation sites that had unique surrounding amino acid sequences, suggesting promiscuity toward the peptide backbone. In this light, the present evidence promotes the concept that for these peptidases the glycan composition, and therefore the presence of specific G sites, rather than the substrate's peptide sequence serves to be a major determinant of O-glycopeptidase specificity. However, we do note that IMPa was unable to cleave at the second glycosylation site in the MUC-1(Tn) peptide, whereas BT4244_m was able to cleave at this site, despite this site possessing an appropriate sugar. This finding implies that there may be some features in the peptide sequence that can influence activity. In this case, the glycosylated residue is followed by a bulky arginine residue. The active site of IMPa in the space this residue would occupy is quite closed in by virtue of the loop structure surrounding the active site, thus potentially causing steric hindrance with the arginine residue (SI Appendix, Fig. S8A ). In contrast, the active site of BT4244_m (and ZmpB_m) is quite open, likely explaining how it can accommodate a large arginine residue that is C terminal to the glycosylated residue (SI Appendix, Fig. S8 B and C). Therefore, there is evidence that the amino acid sequence around the O-glycopeptidase cleavage site can influence activity, but evidence for the presence of specific subsites to accommodate a particular amino acid sequence is presently lacking. The M60-like family as presented by the InterPro database (23) contains over 2,200 sequence entries spanning hundreds of species that include viruses, eukaryotes (including humans), prokaryotes, and archaea. The amino acid sequence signature upon which this family is built includes the tryptophan and asparagine residues that are present in the core GalNAc binding subsite of BT4244, ZmpB, and IMPa. This finding suggests the potential for most, if not all, of the family members to recognize O-glycans and generally supports the proposal of Nakjang et al. that this is a glycoprotein-specific family of peptidases (11) . Indeed, this family, which is better described as a superfamily, includes three MEROPS families (M60, M88, and M98) and likely contains several additional unclassified families. Furthermore, StcE from E. coli is also a glycoproteinspecific protease that is classified into family M66, which is not part of the M60-like superfamily but belongs to the same peptidase clan, MA. Based on the uncomplexed structure of this protein, Yu et al. proposed a sugar-binding site on the surface of the protein adjacent the catalytic machinery (8) . Our observations with the fold-related M60-like peptidases support the sugar-binding site hypothesized for StcE and suggest a mechanism of using glycans as a determinant of substrate recognition analogous to that used by the M60-like peptidases. Thus, there is evidence that the recognition of glycans by peptidases may be quite widespread, implying that glycoprotein turnover is not necessarily a random or untargeted process, or a process that requires preremoval of the glycans by glycoside hydrolases. Organisms or cells that deploy O-glycopeptidases may do so to target specific proteins bearing only the correct glycan modification or even portions of proteins with the appropriate glycans, which in turn implies tailored biological functions for these enzymes. Indeed, the specific targeting to glycan structures, as observed for the three M60-like O-glycopeptidase members studied here, lends itself to the idea of using such enzymes as unique molecular tools to study glycoprotein structure. Furthermore, O-glycopeptidases may find application as glycopeptiligases where their native specificity for O-glycosylated peptides could be harnessed to ligate peptides and glycopeptides to generate designed glycosylated products without the need to significantly engineer the active site environment of the peptidase (24, 25) . The mechanism we have described by which these three M60-like peptidases recognize substrate reveals the intimate utilization of posttranslationally added glycans as a substrate recognition determinant. The participation of posttranslational modification in protein degradation is not unusual with the most common being the targeting of proteins for proteolytic destruction by ubiquitinylation. The specialized processing of N-linked glycans on misfolded proteins in the endoplasmic reticulum also triggers a pathway of proteolytic destruction (26, 27) . The role of the posttranslational modifications in these cases, however, is thought to occur upstream of proteolysis, rather than by the direct recognition of the modification by a protease active site. The mechanism of O-glycopeptidase substrate recognition described here is different from that previously defined and therefore reveals unique insight into how peptidases may directly use posttranslational modifications present on their substrates to influence recognition and peptide bond cleavage.
Materials and Methods
Materials. All reagents and chemicals were from Sigma, unless otherwise stated.
Cloning. The gene fragments encoding BT4244_l (accession code: Q89ZX7, residues 274-857) and BT4244_m (residues 322-857) were amplified from B. thetaiotaomicron VPI-5482 genomic DNA (ATCC 29148). The gene fragments encoding ZmpB_l (accession code: Q0TR08, residues 434-1084) and ZmpB_m (residues 497-1003) were amplified from C. perfringens genomic DNA (ATCC 13124), and the gene fragment encoding IMPa (accession code: Q9I5W4, residues 42-923) was amplified from P. aeruginosa PAO1 genomic DNA (ATCC 47085), using the oligonucleotide primers listed in SI Appendix, Table S4 .
PCR amplified gene fragments were cloned into pET28a (Novagen) via NheI and XhoI restriction sites with the exception of the IMPa gene fragment that was cloned into pET22b (Novagen) through NcoI and XhoI restriction sites according to standard procedures.
In-Fusion HD Cloning Kit (Clontech) was used to introduce BT4244_l-E575Q and BT4244_m-E575A mutants as well as ZmpB_m-E757A and IMPa-E697A mutants to create catalytically inactive peptidases, using primers described in SI Appendix , Table S4 . The resulting BT4244 and ZmpB plasmids encoded the desired polypeptide fused to an N-terminal six-histidine tag by a thrombin protease cleavage site. The resulting IMPa plasmids encoded an N-terminal pelB signal sequence fused to the desired polypeptide, for potential periplasmic localization, followed by a C-terminal six-histidine tag. The DNA sequence fidelity of all constructs was verified by bidirectional sequencing.
Protein Expression and Purification. E. coli strain BL21 (DE3) cells (Invitrogen) transformed with the appropriate recombinant expression plasmid were grown in 2L of sterile 2xYT media supplemented with the suitable antibiotic at 37°C until the culture reached an optical density of ∼0.8 at 600 nm. Cells were cooled at 16°C for 1 h and recombinant protein expression was induced by the addition of isopropyl-β-D-1-thiogalacto-pyranoside (IPTG) to a final concentration of 0.5 mM; incubation was continued overnight at 16°C with shaking. Cells were harvested by centrifugation at 5,000 × g for 10 min at 10°C and disrupted by lysozyme-chemical lysis (28) . Cell lysate was centrifuged at 15,000 × g for 30 min at 10°C and proteins were purified from the cleared cell lysate by Ni 2+ -NTA immobilized metal affinity chromatography. Increased imidazole concentrations (5-500 mM) in binding buffer (20 mM Tris·HCl pH 8.0, 500 mM NaCl) were used to elute the His-tagged protein from the column. Fractions containing pure protein as judged by SDS/PAGE analysis were pooled and concentrated using a stirred ultrafiltration unit (Amicon) with a 10-kDa cutoff membrane (EMD Millipore). The concentrated protein was further purified by size exclusion chromatography using a Sephacryl S-200 HR column (GE Healthcare) in 20 mM Tris·HCl pH 8.0 and 300 mM NaCl. Fractions containing the purified protein were pooled and concentrated using the ultrafiltration unit. The same protocol was used for the periplasmic expression of the IMPa construct and the purification of the protein.
Protein concentration was determined by measuring the absorbance at 280 nm and using the calculated molar extinction coefficients of 125,140 cm −1 ·M Selenomethionine-labeled proteins were produced using either E. coli BL21 (DE3) cells or the methionine auxotrophic strain E. coli B834 (DE3) (Invitrogen) as the expression strain. The defined media (4L) containing selenomethionine was prepared according to the instructions of the manufacturer (AthenaES). The procedure for protein expression and purification was otherwise performed as for the native protein.
In Vitro Mucin Degradation Assays. BSM type I-S, bovine fetuin, and bovine asialofetuin (ASF) were used as substrates in the absence or presence of 50 mM EDTA. Enzymes were incubated with BSM in a 1:175 (wt/wt) ratio for 20 h and with fetuin or ASF in a 1:25 (wt/wt) ratio for 3 h, in 20 mM Tris·HCl pH 7.5 at 37°C. The samples were separated on 10-15% SDS/PAGE and stained for specific glycoprotein detection with the periodic acid-Schiff (PAS) stain (30) . Briefly, gels were fixed in 50% (vol/vol) methanol for 30 min, washed with 5% (vol/vol) acetic acid (3 × 10 min), and incubated with 0.7% (wt/vol) periodic acid in 5% acetic acid solution for 3 h at room temperature (RT). The periodic acid solution was removed, gels were washed with 5% acetic acid (3 × 5 min), and incubated in Schiff reagent (Fisher) overnight at RT. Reddishpink bands of stained glycoprotein would then be visible. Mass Spectrometry. Mass spectrometry experiments were carried out on a Bruker Impact HD mass spectrometer acquiring over a mass range from 150 to 2,200 m/z using an electrospray ionization (ESI) source operated at a temperature of 200°C and a spray voltage of 4.5 kV. The peptides were separated using a Dionex ultimate 3000 UPLC system. In brief, peptides were trapped and desalted on a VanGuard precolumn trap (Waters). The trap was subsequently eluted in line with an Acquity 1.7 μm particle, 100 mm × 1 mm C18 UPLC column (Waters), using a gradient of 3-80% B (buffer A 0.1% formic acid, buffer B 100% acetonitrile) over 5 min, with a 2-min wash method afterward. MS/MS was run in data-dependent acquisition mode with a 0.5-s precursor scan from 150 to 2,200 m/z, followed by 12 fragment scans from 150 to 2,200 m/z of 0.25 s (Impact). MS/MS fragments were identified with a mass tolerance of 20 ppm, with a minimal signal of 300 counts. Extracted ion chromatograms were generated with an extraction window of 0.1 Da from the monoisotopic peak.
Crystallization. Crystals of the different peptidases were obtained at 18°C using sitting-drop vapor diffusion for screening and hanging drop vapor diffusion for optimization. In all cases 1:1 protein to crystallization solution ratios were used. The details of the crystallization conditions and cryoprotection conditions are given in SI Appendix.
Data Collection and Processing. All data collections were done at 100 K. X-ray diffraction data from both BT4244_l-E575Q-Br and BT4244_l-E575Q crystals were collected at the Stanford Synchrotron Radiation Lightsource (SSRL, Stanford) on beamline BL12-2. Diffraction data from both BT4244_m and BT4244-TnAg crystals were collected at the Canadian Light Source (Saskatoon) beamline 08ID-1 (CMCF-ID). In particular, datasets from a bromidesoaked crystal of BT4244_l-E575Q were collected at the peak and inflection and remote wavelengths were determined by fluorescence scan to optimize for the anomalous scattering from bromide.
Diffraction data from crystal of SeMet-IMPa were collected at the Canadian Light Source beamline 08B1-1 at a wavelength optimized for anomalous scattering from the incorporated selenium atoms. The same beamline was used to collect diffraction data from IMPa-6His and IMPa-TAg crystals. Beamline CMCF-ID 08ID-1 at the Canadian Light Source was used to collect diffraction data from IMPa crystal.
Diffraction data from selenomethionine-labeled ZmpB_l crystal were collected at the Canadian Light Source beamline 08B1-1 (CMCF-BM) at the peak wavelength determined by fluorescence scan to optimize for the anomalous scattering from selenium. This beamline was also used to collect the diffraction data from ZmpB_m crystals, whereas diffraction data from ZmpB-STAg crystal was collected at beamline 08ID-1 (CMCF-ID). Diffraction data from both ZmpB_l and ZmpB-BSMfrg crystals were collected at the SSRL beamline BL9-2.
Diffraction data were integrated using MOSFLM (31) or XDS (32) . POINTLESS was used to identify the space group and SCALA was used to scale and merge the data (33), both as implemented in CCP4 (34) . Data collection and processing statistics are shown in SI Appendix, Tables S1-S3.
Structure Solution and Refinement. The structure of the bromide derivative of BT4244_l-E575Q was determined using the multiwavelength anomalous dispersion (MAD) method (35) . Initial automated heavy atom substructure determination, phasing, and density modification were done using autoSHARP (36) . A total of 31 bromide sites were found by ShelxD (37) in the single monomer present in the asymmetric unit and used in the phasing process. BUCCANEER (38) was able to build an incomplete model. This partial model was used in PHASER-EP (39) along with the 31 bromide sites for MR/SAD phasing and phase improvement by Parrot density modification. The cycle of automated model building and phase improvement was repeated until a final run of ARP/wARP (40) resulted in a model of sufficient quality to result in a nearly complete structure when submitted to ARP/wARP as a starting model along with the 2.15-Å resolution BT4244_l-E575Q native dataset. This BT4244_l-E575Q model, with one molecule in the asymmetric unit, was completed by successive rounds of model building with COOT (41) and refinement with REFMAC (42) and was used to solve the structures of both BT4244_m (at 1.65 Å resolution) and BT4244_m-TnAg (at 2.3 Å resolution) by molecular replacement using MOLREP (43) . The final model of each of these structures, with one molecule in the asymmetric unit, was completed as well by successive rounds of model building with COOT and refinement with REFMAC.
The structure of selenomethionine-labeled IMPa-6His (SeMet-IMPa-6His) was solved using the single wavelength anomalous dispersion (SAD) method (44) . ShelxC/D (37) was used with data extending to 2.7 Å to find the six expected selenium atoms present in the single molecule of IMPa-6His in the asymmetric unit. Initial phases were generated using ShelxE (37) and further improved by solvent flattening using DM (34) . BUCCANEER was able to build a model of ∼80% completeness, which was further improved by ARP/wARP to a model with 99% completeness. The resulting model was used to solve the structure of IMPa-6His (at 1.93-Å resolution) by molecular replacement using MOLREP. This model, consisting of a single molecule in the asymmetric unit, was completed by successive rounds of model building with COOT and refinement with REFMAC and used as a starting model to solve both IMPa (at 1.85-Å resolution) and IMPa-TAg (at 2.4-Å resolution) by molecular replacement using MOLREP. The final model of each of these structures, with two molecules in the asymmetric unit, was completed by successive rounds of model building with COOT and refinement with REFMAC.
The structure of selenomethionine-labeled ZmpB_l (SeMet-ZmpB_l) was also determined using the SAD method. Using data to 4.0 Å, ShelxC/D was used to find 20 of the 22 expected selenium atoms present in the two molecules of SeMet-ZmpB_l in the asymmetric unit. Initial phasing and refinement was performed with autoSHARP. PROFESS (34) was used to determine the noncrystallographic symmetry (NCS) operators relating the two SeMet-ZmpB_l molecules in the asymmetric unit. Phase improvement was achieved by solvent flattening with NCS averaging using DM. The resulting electron maps were of relatively low quality but did have regions of interpretable secondary structure. BUCCANEER (fast build) was able to build a partial model comprising 50% of the polypeptide and backbone only. This partial model was used in PHASER-EP along with the 20 selenium sites for MR/SAD phasing. The resulting phases were improved by solvent flattening with NCS averaging using DM and gave a substantial improvement in the electron density maps. The cycle of automated model building, MR/SAD phasing, and density improvement was repeated an additional two times. A final run of BUCCANEER resulted in a model of ∼60% completeness with 30% of the amino acid sidechains docked. This partial model was of sufficient quality to result in an automatically built model of 85% completeness when submitted to ARP/wARP as a starting model along with the 2.15-Å resolution ZmpB_l native dataset. This model, consisting of two molecules in the asymmetric unit, was completed by successive rounds of model building with COOT and refinement with REFMAC. The final model of the ZmpB_l protein backbone was used to solve the structures of ZmpB_m (at 1.66-Å resolution), ZmpB_m-BSMfrg (at 1.60-Å resolution) and ZmpB_m-STAg (at 2.0-Å resolution), by molecular replacement using MOLREP. The final model of each of these structures, with one molecule in the asymmetric unit, was completed by successive rounds of model building with COOT and refinement with REFMAC.
In all cases, the final addition of water molecules was performed in COOT with FINDWATERS and manually checked after refinement. In all datasets, refinement procedures were monitored by flagging 5% of all observations as "free" (45) . Model validation was performed with MOLPROBITY (46) . Refinement statistics are shown in SI Appendix, Tables S1-S3. Structure figures were generated using PyMOL (the PyMOL Molecular Graphics System, version 1.6.0.0, Schrödinger). Electrostatic potential surfaces were generated using APBS (47) . The core-2 glycan model was generated using GLYCAM (48) .
